Real-time enrollment status for this iga monoclonal gammopathy of undetermined significance clinical trial
Current Status
Recruiting
Checked: July 14, 2026 at 12:02 AM UTC
| NCT Number | NCT07209371 |
| Recruiting Status | Recruiting |
| Condition | IgA Monoclonal Gammopathy of Undetermined Significance |
| Phase | Clinical Trial |
| Target Enrollment | 50 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Fred Hutchinson Cancer Center |
| Last Updated on CT.gov | April 20, 2026 (Apr 20, 2026) |
As of July 14, 2026: Clinical trial NCT07209371 is currently recruiting participants. This clinical trial study for iga monoclonal gammopathy of undetermined significance is actively seeking new participants at 1 location across the United States. The study is sponsored by Fred Hutchinson Cancer Center. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07209371 is actively recruiting participants as of July 14, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07209371 was last updated Apr 20, 2026 (April 20, 2026). HelloStudys verifies this status automatically.